Clinical Trial Update: Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.

View source ↗

Summary

A completed clinical trial evaluating the association between inflammatory biomarkers and empagliflozin treatment in cardiovascular disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Stable Angina

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Damanhour University | Conditions: Stable Angina, Heart Failure | Status: COMPLETED